In a report of 472 patients by Bataille P et al., 109 drugs that induce CDILE were identified, including anti-TNFα, proton pump inhibitors, anti-cancer drugs, especially checkpoint inhibitors, as emerging drugs in CDILE (26). Here, TNF is linked to cancer.